These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20173752)

  • 1. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.
    Barouch DH; O'Brien KL; Simmons NL; King SL; Abbink P; Maxfield LF; Sun YH; La Porte A; Riggs AM; Lynch DM; Clark SL; Backus K; Perry JR; Seaman MS; Carville A; Mansfield KG; Szinger JJ; Fischer W; Muldoon M; Korber B
    Nat Med; 2010 Mar; 16(3):319-23. PubMed ID: 20173752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV vaccines: mosaic approach to virus diversity.
    Corey L; McElrath MJ
    Nat Med; 2010 Mar; 16(3):268-70. PubMed ID: 20208511
    [No Abstract]   [Full Text] [Related]  

  • 3. Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.
    Santra S; Liao HX; Zhang R; Muldoon M; Watson S; Fischer W; Theiler J; Szinger J; Balachandran H; Buzby A; Quinn D; Parks RJ; Tsao CY; Carville A; Mansfield KG; Pavlakis GN; Felber BK; Haynes BF; Korber BT; Letvin NL
    Nat Med; 2010 Mar; 16(3):324-8. PubMed ID: 20173754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys.
    Stephenson KE; SanMiguel A; Simmons NL; Smith K; Lewis MG; Szinger JJ; Korber B; Barouch DH
    J Virol; 2012 Nov; 86(21):11434-40. PubMed ID: 22896617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens.
    Santra S; Muldoon M; Watson S; Buzby A; Balachandran H; Carlson KR; Mach L; Kong WP; McKee K; Yang ZY; Rao SS; Mascola JR; Nabel GJ; Korber BT; Letvin NL
    Virology; 2012 Jul; 428(2):121-7. PubMed ID: 22521913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination.
    Kong WP; Wu L; Wallstrom TC; Fischer W; Yang ZY; Ko SY; Letvin NL; Haynes BF; Hahn BH; Korber B; Nabel GJ
    J Virol; 2009 Mar; 83(5):2201-15. PubMed ID: 19109395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys.
    Kaufman DR; Li F; Cruz AN; Self SG; Barouch DH
    Vaccine; 2012 Jan; 30(3):506-9. PubMed ID: 22133509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen.
    Weaver EA; Lu Z; Camacho ZT; Moukdar F; Liao HX; Ma BJ; Muldoon M; Theiler J; Nabel GJ; Letvin NL; Korber BT; Hahn BH; Haynes BF; Gao F
    J Virol; 2006 Jul; 80(14):6745-56. PubMed ID: 16809280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
    Hulot SL; Korber B; Giorgi EE; Vandergrift N; Saunders KO; Balachandran H; Mach LV; Lifton MA; Pantaleo G; Tartaglia J; Phogat S; Jacobs B; Kibler K; Perdiguero B; Gomez CE; Esteban M; Rosati M; Felber BK; Pavlakis GN; Parks R; Lloyd K; Sutherland L; Scearce R; Letvin NL; Seaman MS; Alam SM; Montefiori D; Liao HX; Haynes BF; Santra S
    J Virol; 2015 Jun; 89(12):6462-80. PubMed ID: 25855741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance.
    Yang OO; Ali A; Kasahara N; Faure-Kumar E; Bae JY; Picker LJ; Park H
    J Virol; 2015 Jan; 89(2):1195-204. PubMed ID: 25378501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Barouch DH; Tomaka FL; Wegmann F; Stieh DJ; Alter G; Robb ML; Michael NL; Peter L; Nkolola JP; Borducchi EN; Chandrashekar A; Jetton D; Stephenson KE; Li W; Korber B; Tomaras GD; Montefiori DC; Gray G; Frahm N; McElrath MJ; Baden L; Johnson J; Hutter J; Swann E; Karita E; Kibuuka H; Mpendo J; Garrett N; Mngadi K; Chinyenze K; Priddy F; Lazarus E; Laher F; Nitayapan S; Pitisuttithum P; Bart S; Campbell T; Feldman R; Lucksinger G; Borremans C; Callewaert K; Roten R; Sadoff J; Scheppler L; Weijtens M; Feddes-de Boer K; van Manen D; Vreugdenhil J; Zahn R; Lavreys L; Nijs S; Tolboom J; Hendriks J; Euler Z; Pau MG; Schuitemaker H
    Lancet; 2018 Jul; 392(10143):232-243. PubMed ID: 30047376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.
    Seaman MS; Xu L; Beaudry K; Martin KL; Beddall MH; Miura A; Sambor A; Chakrabarti BK; Huang Y; Bailer R; Koup RA; Mascola JR; Nabel GJ; Letvin NL
    J Virol; 2005 Mar; 79(5):2956-63. PubMed ID: 15709015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.
    Fischer W; Perkins S; Theiler J; Bhattacharya T; Yusim K; Funkhouser R; Kuiken C; Haynes B; Letvin NL; Walker BD; Hahn BH; Korber BT
    Nat Med; 2007 Jan; 13(1):100-6. PubMed ID: 17187074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
    Walsh SR; Moodie Z; Fiore-Gartland AJ; Morgan C; Wilck MB; Hammer SM; Buchbinder SP; Kalams SA; Goepfert PA; Mulligan MJ; Keefer MC; Baden LR; Swann EM; Grant S; Ahmed H; Li F; Hertz T; Self SG; Friedrich D; Frahm N; Liao HX; Montefiori DC; Tomaras GD; McElrath MJ; Hural J; Graham BS; Jin X;
    J Infect Dis; 2016 Feb; 213(4):541-50. PubMed ID: 26475930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.
    Currier JR; Robb ML; Michael NL; Marovich MA
    J Transl Med; 2011 Dec; 9():212. PubMed ID: 22152192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22).
    Stephenson KE; Wegmann F; Tomaka F; Walsh SR; Tan CS; Lavreys L; Ansel JL; Kanjilal DG; Jaegle K; Nkolola JP; Peter L; Fogel R; Bradshaw C; Tyler A; Makoni T; Howe L; Quijada D; Chandrashekar A; Bondzie EA; Borducchi EN; Yanosick KE; Hendriks J; Nijs S; Truyers C; Tolboom J; Zahn RC; Seaman MS; Alter G; Stieh DJ; Pau MG; Schuitemaker H; Barouch DH
    Lancet HIV; 2020 Jun; 7(6):e410-e421. PubMed ID: 32078815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
    Barouch DH; Stephenson KE; Borducchi EN; Smith K; Stanley K; McNally AG; Liu J; Abbink P; Maxfield LF; Seaman MS; Dugast AS; Alter G; Ferguson M; Li W; Earl PL; Moss B; Giorgi EE; Szinger JJ; Eller LA; Billings EA; Rao M; Tovanabutra S; Sanders-Buell E; Weijtens M; Pau MG; Schuitemaker H; Robb ML; Kim JH; Korber BT; Michael NL
    Cell; 2013 Oct; 155(3):531-9. PubMed ID: 24243013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic competition in CD4
    Kallas EG; Grunenberg NA; Yu C; Manso B; Pantaleo G; Casapia M; Baden LR; Valencia J; Sobieszczyk M; Van Tieu H; Allen M; Hural J; Graham BS; Kublin J; Gilbert PB; Corey L; Goepfert PA; McElrath MJ; Johnson RP; Huang Y; Frahm N
    Sci Transl Med; 2019 Nov; 11(519):. PubMed ID: 31748227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.